tiprankstipranks
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
US Market
LOVFF
Cannara Biotech
RESEARCH TOOLSreports
Want to see LOVFF full AI Analyst Report?

Cannara Biotech (LOVFF) Income Statement

11 Followers

Cannara Biotech Income Statement

Last quarter (Q1 2026), Cannara Biotech's total revenue was C$30.11M, an increase of 20.11% from the same quarter last year. In Q1, Cannara Biotech's net income was C$1.04M. See Cannara Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 25Aug 24Nov 23Aug 22Nov 21
Total Revenue
C$ 107.32MC$ 81.75MC$ 57.26MC$ 35.84MC$ 17.02M
Gross Profit
C$ 47.22MC$ 29.79MC$ 27.23MC$ 17.33MC$ 10.30M
Operating Expenses
C$ 25.02MC$ 19.71MC$ 15.34MC$ 12.36MC$ 10.00M
Depreciation and Amortization
C$ 6.40MC$ 6.35MC$ 4.94MC$ 3.92MC$ 3.03M
EBITDA
C$ 28.18MC$ 15.16MC$ 15.77MC$ 9.54MC$ 3.22M
Operating Income
C$ 22.20MC$ 10.08MC$ 11.89MC$ 3.67MC$ 192.60K
Other Income/Expenses
C$ -4.10MC$ -5.59MC$ -4.94MC$ -2.64MC$ -1.79M
Pretax Income
C$ 18.10MC$ 4.48MC$ 6.95MC$ 2.31MC$ -1.53M
Net Income
C$ 13.08MC$ 6.44MC$ 6.95MC$ 2.31MC$ -3.09M
Per Share Metrics
Basic EPS
C$ 0.14C$ 0.07C$ 0.08C$ 0.03C$ -0.04
Diluted EPS
C$ 0.14C$ 0.07C$ 0.08C$ 0.03C$ -0.04
Weighted Average Shares Outstanding
 93.40M 90.07M 89.30M 87.67M 76.52M
Weighted Average Shares Outstanding (Diluted)
 92.37M 91.39M 89.30M 87.84M 76.52M
Currency in CAD

Cannara Biotech Earnings and Revenue History